Login


TI Ref No : 528552716
Description : Conclusion Of Non-exclusive Agreements On Pharmaceuticals With The Active Ingredient Fremanezumab (atc Code
Date : 2026-02-06
Deadline : 2026-08-05
Document Type : Tenders
View Details
Whats app